3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
8
Terminated
5
Recruiting
4
Withdrawn
2
Unknown
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
86
Thoracic
7
Genitourinary
6
Gastrointestinal
6
Head & Neck
5
Gynecologic
5
Dermatologic
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
CNS
1
Conditions
Glioblastoma
81
Brain Neoplasms
77
Glioma
61
Neoplasms
16
Neuroblastoma
15
Meningioma
14
Medulloblastoma
13
Neurofibromatosis 1
10
Meningeal Carcinomatosis
9
Ependymoma
9
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
8
Neurologic Manifestations
6
Diffuse Intrinsic Pontine Glioma
6
Spinal Cord Neoplasms
5
Recurrence
5
Central Nervous System Neoplasms
5
Astrocytoma
5
Pheochromocytoma
4
Paraganglioma
4
Lung Neoplasms
4
Sarcoma
3
Rhabdoid Tumor
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Oligodendroglioma
3
Neuroma, Acoustic
3
Neurofibroma, Plexiform
3
Head and Neck Neoplasms
3
Ganglioneuroblastoma
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Triple Negative Breast Neoplasms
×
CNS
×
Clear all
NCT07458113
2026-03-09
BERLIN
Yale University
Phase 2
Not yet recruiting
20 enrolled